Arvinas (ARVN) Earnings Date & Reports

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ARVN is expected to report earnings to rise 58.73% to -100 cents per share on May 06

Q1'25

Est.

$-1.00

Q4'24

Beat

by $0.33

Q3'24

Beat

by $0.16

Q2'24

Beat

by $0.59

Q1'24

Beat

by $0.43

The last earnings report on February 11 showed earnings per share of -62 cents, beating the estimate of -95 cents. With 145.84K shares outstanding, the current market capitalization sits at 614.82M.

View a ticker or compare two or three

Compare

ARVN